This study investigates the safety of an investigational pneumococcal vaccine called PCV21 in healthy infants. The study compares PCV21 to a licensed 20-valent pneumococcal conjugate vaccine. Infants participating in the study will be between 42 to 89 days old. The purpose is to understand the safety profile of the investigational …
This study investigates a health condition to understand the effects of an investigational medication. The purpose of this study is to gather information about how the medication interacts with the body and its potential impact on the health condition.Participants in this study will undergo various procedures to monitor their health …
This study investigates the experience of using a virtual waiting room. The purpose is to understand how this digital tool can impact patient satisfaction and efficiency during medical appointments.Participants will use a virtual waiting room before their medical appointments. They will provide feedback on their experience, including ease of use …
Who can participate: Adults aged 18-65 with a diagnosis of hypertension who are otherwise healthy may be eligible to participate. Key exclusion criteria include pregnancy, current use of similar medications, and significant comorbid conditions.Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The …
This study investigates the effects of an investigational medication on vaccine responses in adults with moderate-to-severe atopic dermatitis, a skin condition that causes itchy and inflamed patches of skin. The purpose of this study is to compare immune responses to vaccines given alongside the investigational medication versus a placebo. Participants …
This study investigates immune-mediated thrombotic thrombocytopenic purpura, also known as iTTP. iTTP is a rare blood disorder where blood clots form in small blood vessels throughout the body, leading to low platelet counts and potential organ damage.Participants will be asked to complete a brief questionnaire to determine eligibility. This is …
This study investigates the long-term effects of an investigational medication on the skin barrier in children with moderate-to-severe atopic dermatitis (AD). Atopic dermatitis is a skin condition that causes dry, itchy, and inflamed skin. The study will measure skin barrier function by assessing transepidermal water loss, which is the amount …
This study investigates prurigo nodularis, a skin condition characterized by itchy bumps. The purpose of the study is to understand how the investigational medication affects children and adolescents with this condition. Prurigo nodularis can cause intense itching and discomfort, and this study aims to explore potential treatment options for managing …
This study investigates an investigational medication for individuals with Type 1 diabetes (T1D). Type 1 diabetes is a chronic disease where the body's defense system mistakenly attacks specific cells within the pancreas, which make insulin. Insulin helps control sugar in the blood. When these cells are damaged, they cannot make …
Who can participate: Participants aged 10 to 17 who have been diagnosed with the specific condition and meet other health criteria are eligible to participate.Study details: Participants will receive either the investigational treatment or a placebo, which is a substance with no active medication, to compare outcomes. The study involves …
